

Abstracts / Journal of Clinical Virology 82S (2016) S1–S142
S117
more, for monitoring of intensity, RSV-specific denominators are
needed.
http://dx.doi.org/10.1016/j.jcv.2016.08.234Abstract no: 253
Presentation at ESCV 2016: Poster 195
Herpes Simplex 1-2 in broncho alveolar fluid: A
5 years retrospective study
Catherine Mengelle
1 ,∗
, Jacques Izopet
1 , 2,
Emmanuel Bories
1, Aurélie Lecour
1,
Jean-Michel Mansuy
11
Department of Virology, Toulouse University
Hospital, Toulouse, France
2
Department of Physiopathology, Toulouse Purpan,
Unité Inserm U563, Toulouse, France
Aim:
Respiratory viruses are very often detected in pneumo-
nia thanks to uniplex and multiplex real-time PCR techniques.
Moreover viruses that are not primilarly the cause of respiratory
infections may also be detected such as HSV 1-2, varicella zoster
virus and cytomegalovirus.
The aim of our study was to analyze the prevalence of other
respiratory infections among broncho-alveolar lavages (BAL) posi-
tive for HSV 1-2. The clinical outcome of patients according to the
anti HSV 1-2 treatment was also analyzed.
Material and methods:
Data from hospitalized patients
suffering from serious respiratory symptoms and whose broncho-
alveolar lavages were positive for HSV 1-2 by an in-house real-time
PCR were analyzed.
Nucleic acids (NA) had been extracted with the MagNA Pure
96 DNA and Viral NA Small Volume kit
®
on the MagNA Pure 96
TM
instrument (Roche Molecular Diagnostics, Meylan, France).
Samples had been tested for 16 respiratory viruses (influenza
A and B, parainfluenza 1–4, respiratory syncytial viruses A and
B, human metapneumovirus, coronaviruses 229E, OC43 and NL63,
rhinoviruses, enteroviruses, bocaviruses and adenoviruses) with a
multiplex RT-PCR (Anyplex
TM
II RV16 Detection
®
, Seegene) on the
CFX96
TM
Real-Time System (Biorad diagnostics).
NA had also been tested for cytomegalovirus, varicella zoster
virus employing amonoplex in-house PCR on the Light Cycler or the
Light Cycler 480
TM
(Roche Molecular Diagnostics, Meylan, France).
Data were analyzed on StataTM software (StataCorp, Texas)
using the exact Fisher test.
Results:
Between 2011 and 2015, 122 (73 males) patients
attending an intensive care unit in the Toulouse University Hos-
pital were selected with a HSV 1-2 positive result (mean age 62;
24–86). 119 samples were HSV-1 and three were HSV-2.
117 had been tested with the Anyplex
TM
II RV16 Detection
Seegene
®
. All the viruses of the panel had been detected except
parainfluenza 1, 2 and 4, human metapneumovirus and bocavirus;
Influenza viruses were the most detected (
n
= 13), followed by rhi-
novirus (
n
= 6), respiratory syncytial virus (
n
= 5) and adenovirus
(
n
= 4). 117 samples had been tested for cytomegalovirus (26 posi-
tive), and 90 for varicella zoster virus (negative).
28 among the 78 samples that tested positive for HSV 1-2
during the winter season (November to April) were also positive
for another respiratory virus. During the summer season (May to
October) 44 samples tested positive for HSV 1-2 with only 4 in
coinfection (
p
< 0.005).
The mortality rate did not differ between the HSV 1-2 positive
patients treated with acyclovir or valacyclovir (
n
= 57) and those
who were not (
p
= ns).
Conclusions:
Our results indicate that HSV 1-2 infection is
frequent among patients hospitalized in intensive care unit. Dur-
ing the winter season this infection is linked to other respiratory
viruses.
The apparent clinical inefficiency of anti HSV 1-2 treatment indi-
cates that the presence of the virus is more a witness of a clinically
poor condition rather than a cause of it.
http://dx.doi.org/10.1016/j.jcv.2016.08.235Abstract no: 255
Presentation at ESCV 2016: Poster 196
Three years (2013–2016) of human respiratory
syncytial virus surveillance at a tertiary hospital
in Catalonia, Spain
Laura Gimferrer
∗
, José Angel Rodrigo,
Cristina Andrés, Isabel Dolores Oriolo,
Maria Gema Codina, Paula Peremiquel,
Maria del Carmen Martin, Francisco Fuentes,
Rosario Saiz, Pilar Alcubilla, Magda Campins,
Tomàs Pumarola, Andrés Antón
Hospital Universitari Vall d’Hebron, Universitat
Autònoma de Barcelona, Spain
Background:
Human respiratory syncytial virus (HRSV) is the
most common respiratory pathogen and the main cause of lower
respiratory tract infections among infants and young children. Its
genome is a lineal single-stranded negative-sense RNA of approx-
imately 15 kb that contains 10 genes encoding 11 proteins. The G
glycoprotein in the viral envelope plays an essential role in the virus
attachment. Antigenic and genetic differences in this protein lead
classify HRSV into two different groups, HRSV-A and HRSV-B. Fur-
thermore, based on the hypervariable region 2 (HVR-2) located in
the C-terminal domain of the G protein several genotypes have
been described. Selection pressure drives G protein to continu-
ously evolve, resulting in the likely replacement of predominant
genotype season by season. In the present study the epidemiology
of HRSV viruses detected in respiratory specimens from patients
attended at the Hospital Universitari Vall d’Hebron in Barcelona
(Spain) during three consecutive years (from 2013 to 2016) has
been described.
Material and methods:
FromOctober 2013 (week 40) to March
2016 (week 20) respiratory specimens frompatientswere collected
for laboratory confirmation of respiratory virus infection using
immunochromatography (Binax Now RSV Card, Allere Scarbor-
ough Inc, USA), immunofluorescence (D
3
Ultra 8
TM
DFA Respiratory
Virus Screening & Identification Kit, Diagnostic HYBRIDS, USA) or
real-time multiplex RT-PCR (Anyplex II RV16 Detection Kit, See-
gene, Korea) assays. A nucleoprotein-specific real time RT-PCR was
performed to determine HRSV group. In addition, phylogenetic
analyses and molecular characterizations were carried out using
MEGAv5.2 software based on the HVR-2 sequence from a repre-
senting sampling of HRSV per week.
Results:
A total of 16552 specimens were collected, of which
1324 (8.3%) were positive for HRSV. The virus showed a seasonal
pattern of circulation, previous to influenza annual epidemics, with
a maximum detection rates in the weeks 52 or 53 in all three
seasons. Viruses belonging to both HRSV groups were detected:
HRSV-A (662; 50%), HRSV-B (579, 44%), HRSV-A/B co-infection (8;
<1%), and 75 (6%) remained unsubtyped. There was an alterna-
tion in the predominance of HRSV group by season; while HRSV-B
was predominant during the first two seasons, HRSV-A became it
during the third. Based on HVR-2 phylogenetic analyses, HRSV-A
viruses belonged to ON1 genotype (153; 99%), but 2 (1%) to NA1.